Global Epidemiology and Real-World Data on High Volume Hemodiafiltration

As the clinical experience with HDF accumulates globally, it is worth examining the evidence for this kidney replacement therapy as used in routine clinical care. Such real-world evidence is increasingly recognized as valuable by clinicians and may inform regulatory decisions. In this presentation, we will focus on emerging global real-world data derived from routine clinical practices and examine how these data may complement those derived from clinical trials.